Pharmaceutical Care Management Association v. Department of Health and Human Services et al.

Why this Matters:

The plaintiff challenges price transparency regulations requiring health insurers to disclose prescription drug pricing data in a machine-readable format—arguing that such requirements violate the Administrative Procedure Act. Broad health care transparency and disclosure measures can help facilitate more informed health care decisions for consumers, promote higher value care, and potentially lower health care prices.

Potential Impact:

Preventing the federal government from crafting price transparency regulations and promoting greater public disclosure could lead to consumers losing a valuable tool to make informed decisions and potentially face higher health care prices.